These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 31932479)
1. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation. Liu L; Yu L; Zeng C; Long H; Duan G; Yin G; Dai X; Lin Z Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932479 [TBL] [Abstract][Full Text] [Related]
2. HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression. Liu L; Long H; Wu Y; Li H; Dong L; Zhong JL; Liu Z; Yang X; Dai X; Shi L; Ren M; Lin Z Cell Signal; 2018 Oct; 50():90-99. PubMed ID: 29958993 [TBL] [Abstract][Full Text] [Related]
3. The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1. Yang Q; Chen X; Zhang Y; Hu S; Hu F; Huang Y; Ma T; Hu H; Tian H; Tian S; Ji YX; She ZG; Zhang P; Zhang XJ; Hu Y; Yang H; Yuan Y; Li H Hepatology; 2021 Dec; 74(6):3018-3036. PubMed ID: 34272738 [TBL] [Abstract][Full Text] [Related]
4. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation. Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878 [TBL] [Abstract][Full Text] [Related]
5. HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation. Xu YM; Wang HJ; Chen F; Guo WH; Wang YY; Li HY; Tang JH; Ding Y; Shen YC; Li M; Xuan WY; Liu LH; Wang J; Wang XR; Gao ZJ; Liang XB; Su DM Oncotarget; 2015 Dec; 6(40):42854-67. PubMed ID: 26536657 [TBL] [Abstract][Full Text] [Related]
6. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression. Fan Y; Wang J; Xu Y; Wang Y; Song T; Liang X; Jin F; Su D Cell Commun Signal; 2021 Feb; 19(1):18. PubMed ID: 33588886 [TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradation. Chung C; Yoo G; Kim T; Lee D; Lee CS; Cha HR; Park YH; Moon JY; Jung SS; Kim JO; Lee JC; Kim SY; Park HS; Park M; Park DI; Lim DS; Jang KW; Lee JE Biochem Biophys Res Commun; 2016 Oct; 479(2):152-158. PubMed ID: 27475501 [TBL] [Abstract][Full Text] [Related]
8. HRD1 promotes non-small cell lung carcinoma metastasis by blocking autophagy-mediated MIEN1 degradation. Zeng C; Guo J; Wu J; Che T; Huang X; Liu H; Lin Z J Biol Chem; 2023 Jun; 299(6):104723. PubMed ID: 37075843 [TBL] [Abstract][Full Text] [Related]
9. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination. Jeon YK; Kim CK; Hwang KR; Park HY; Koh J; Chung DH; Lee CW; Ha GH Cell Death Differ; 2017 Mar; 24(3):469-480. PubMed ID: 28009353 [TBL] [Abstract][Full Text] [Related]
10. miR‑150 promotes the proliferation and migration of non‑small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway. Jiang K; Shen M; Chen Y; Xu W Oncol Rep; 2018 Aug; 40(2):943-951. PubMed ID: 29901178 [TBL] [Abstract][Full Text] [Related]
11. HRD1 functions as a tumor suppressor in ovarian cancer by facilitating ubiquitination-dependent SLC7A11 degradation. Wang Y; Wang S; Zhang W Cell Cycle; 2023 May; 22(9):1116-1126. PubMed ID: 36809917 [TBL] [Abstract][Full Text] [Related]
12. HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)*. Schiedel M; Lehotzky A; Szunyogh S; Oláh J; Hammelmann S; Wössner N; Robaa D; Einsle O; Sippl W; Ovádi J; Jung M Chembiochem; 2020 Dec; 21(23):3371-3376. PubMed ID: 32672888 [TBL] [Abstract][Full Text] [Related]
13. HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancer. Guo X; Wang A; Wang W; Wang Y; Chen H; Liu X; Xia T; Zhang A; Chen D; Qi H; Ling T; Piao HL; Wang HJ Mol Oncol; 2021 Feb; 15(2):642-656. PubMed ID: 33207079 [TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Liu PY; Xu N; Malyukova A; Scarlett CJ; Sun YT; Zhang XD; Ling D; Su SP; Nelson C; Chang DK; Koach J; Tee AE; Haber M; Norris MD; Toon C; Rooman I; Xue C; Cheung BB; Kumar S; Marshall GM; Biankin AV; Liu T Cell Death Differ; 2013 Mar; 20(3):503-14. PubMed ID: 23175188 [TBL] [Abstract][Full Text] [Related]
15. Role of the E3 ubiquitin ligase HRD1 in the regulation of serotonin transporter function. Taguchi K; Kaneko M; Motoike S; Harada K; Hide I; Tanaka S; Sakai N Biochem Biophys Res Commun; 2021 Jan; 534():583-589. PubMed ID: 33243462 [TBL] [Abstract][Full Text] [Related]
16. HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth. Queisser MA; Dada LA; Deiss-Yehiely N; Angulo M; Zhou G; Kouri FM; Knab LM; Liu J; Stegh AH; DeCamp MM; Budinger GR; Chandel NS; Ciechanover A; Iwai K; Sznajder JI Am J Respir Crit Care Med; 2014 Sep; 190(6):688-98. PubMed ID: 25118570 [TBL] [Abstract][Full Text] [Related]
17. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer. Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265 [TBL] [Abstract][Full Text] [Related]
18. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target. Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711 [TBL] [Abstract][Full Text] [Related]
19. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth. Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis. Yu L; Dong L; Li H; Liu Z; Luo Z; Duan G; Dai X; Lin Z Oncogene; 2020 May; 39(22):4450-4464. PubMed ID: 32361710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]